Skip to main content
TISSUE REPAIR LTD logo

TISSUE REPAIR LTD — Investor Relations & Filings

Ticker · TRP ISIN · AU0000180887 ASX Professional, scientific and technical activities
Open in API
Filings indexed 139 across all filing types
Latest filing 2026-04-29 Interim / Quarterly Rep…
Country AU Australia
Listing ASX TRP

About TISSUE REPAIR LTD

https://tissuerepair.com.au/

Tissue Repair Ltd is a clinical-stage biopharmaceutical company focused on the development of advanced wound healing and skin repair agents. The company’s core technology centers on Glucoprime, a proprietary yeast-derived beta-glucan designed to stimulate the innate immune system and accelerate the body's natural healing processes. Its lead candidate, TR-987, is being developed for the treatment of chronic wounds, such as venous leg ulcers, and for use in post-procedural recovery following aesthetic treatments. By targeting the inflammatory phase of wound healing, the technology aims to improve clinical outcomes and reduce recovery times. The company focuses on addressing unmet needs in both the medical wound care and cosmetic dermatology markets through its specialized biological platform.

Recent filings

Filing Released Lang Actions
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 436.1KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4C Quarterly cash flow report' and references ASX Listing Rule 4.7B, which mandates quarterly cash flow reporting for listed entities. It contains detailed financial data including cash flows from operating, investing, and financing activities for the quarter ended 31 March 2026. The document includes operational updates, clinical trial progress, and financial summaries. The length is about 15,000 characters, indicating it is a full report rather than a brief announcement. The content is consistent with a comprehensive interim or quarterly financial report rather than an earnings release or annual report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q3 2026
2026-04-29 English
Director Appointment 1 page 232.0KB
Board/Management Information Classification · 93% confidence The document is an ASX announcement titled “Director Appointment” and details the appointment of Mr Peter Scutt as an Executive Director, including his consultancy agreement terms and biography. This clearly falls under announcements of changes in the company’s board or senior management, matching the Board/Management Information category (MANG).
2026-04-19 English
Initial Director's Interest Notice - PS 2 pages 1.1MB
Director's Dealing Classification · 95% confidence The document is an Appendix 3X “Initial Director’s Interest Notice” filed under ASX Listing Rule 3.19A.1, detailing a director’s relevant interests in securities (unlisted options and fully paid ordinary shares) and contractual interests. This is a classic insider transaction disclosure by a director. It falls under “Director's Dealing” filings.
2026-04-19 English
Notification of cessation of securities - TRP 5 pages 16.5KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the lapse or cessation of certain securities (options) for the entity Tissue Repair Ltd. It provides specific information about the securities that have ceased, the reasons for cessation, and the updated issued capital following these changes. The document is a formal announcement to the ASX regarding changes in the company's securities, specifically the cessation of certain options. It does not contain financial statements, management discussion, or detailed financial results. It is not a report but an official notification about securities cessation. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2026-03-02 English
Appendix 4D and Half Year Report to 31 December 2025 20 pages 1.0MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Tissue Repair Ltd Appendix 4D Half-year report' and references the half-year ended 31 December 2025, indicating it is a semi-annual financial report. It includes detailed financial data such as revenues, losses, net tangible assets, and cash flows. The document contains a directors' report, auditor's independence declaration, consolidated financial statements, and notes, which are typical components of an interim or quarterly report. The presence of an auditor's review report attached as part of the half-year financial report further supports this classification. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2026
2026-02-26 English
Notification regarding unquoted securities - TRP 7 pages 23.4KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of new unquoted options under an employee incentive scheme by Tissue Repair Ltd. It includes specifics such as security descriptions, issue dates, exercise prices, and total securities issued. The document is a formal notification to the ASX about new securities issued, which fits the category of announcements related to share issues or capital changes. It is not a full financial report, earnings release, or management discussion, but rather a regulatory announcement about new securities issued. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length (8752 characters) and content confirm it is a detailed notification rather than a brief announcement or a report publication announcement.
2026-02-26 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.